Litcius/Paper detail

Predictive Values of Biochemical Markers As Early Indicators for Severe COVID-19 Cases in Admission

Emin Gemcioğlu, Mehmet Davutoğlu, Ramis Çatalbaş, Berkan Karabuğa, Enes Kaptan, Adalet Aypak, Ayşe Kaya Kalem, Mustafa Özdemir, Necati Y Yeşilova, Emra Asfuroğlu Kalkan, Musa Cıvak, Orhan Küçükşahin, Abdülsamet Erden, İhsan Ateş

2021Future Virology29 citationsDOIOpen Access PDF

Abstract

Aim: COVID-19 is a pandemic that causes high morbidity and mortality, especially in severe patients. In this study, we aimed to search and explain the relationship between biochemical markers, which are more common, easily available and applicable to diagnose and to stage the disease. Materials & methods: In this study, 609 patients were evaluated retrospectively. 11 biochemical parameters were included in analysis to explain the relationship with severity of disease. Results: Nearly, all the parameters that have been evaluated in this study were statistically valuable as a predictive parameter for severe disease. Areas under the curve of blood urea nitrogen (BUN)/albumin ratio (BAR), CALL score and lymphocyte/C-reactive protein ratio were 0.795, 0.778 and 0.770. The BUN/BAR and neutrophil/albumin ratios provide important prognostic information for decision-making in severe patients with COVID-19. Conclusion: High BUN/BAR and neutrophil/albumin ratios may be a better predictor of severity COVID-19 than other routinely used parameters in admission.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Liver Disease Diagnosis and TreatmentCOVID-19 Clinical Research StudiesInflammatory Biomarkers in Disease Prognosis